Royalty Pharma Signs $1.8 Billion Revolving Credit Agreement
Royalty Pharma Signs $1.8 Billion Revolving Credit Agreement
Royalty Pharma PLC (NASDAQ: RPRX) announced on May 22, 2026 that it has entered into a $1.8 billion unsecured revolving credit agreement. According to the SEC filing, the revolving credit facility will mature on May 22, 2031.
Key Details of the Agreement
The credit agreement provides Royalty Pharma with flexible financing capacity. The company plans to use the funds for general corporate purposes and potential investments.
About the Company
Royalty Pharma is a leading investor in biopharmaceutical royalties. This new credit agreement is seen as an important step to support the company's growth strategy.
Impacted Symbols
Symbols affected by this headline and their sentiment signals
The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.
More Headlines
Tokyo Core Inflation Slows, Remains Below BOJ Target
Tokyo Core Inflation Slows, Remains Below BOJ Target
…Nikkei May Rise on Hopes for U.S.-Iran Peace Deal
Nikkei May Rise on Hopes for U.S.-Iran Peace Deal
…Australian Pension Fund HUB24 Faces Regulatory Scrutiny
Australian Pension Fund HUB24 Faces Regulatory Scrutiny
…